Mediomics LLC

St. Louis, MO

UEI
TT17CQEWLNF1
CAGE
46JZ5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Woman Owned Business
  • Woman Owned Small Business
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
815 Wenneker Dr, St. Louis, MO 63124, USA
Website
mediomics.com
Founded
2001
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Developing novel tools for site-specific quantitative analysis of RNA modifications HHSN261201700021C National Cancer Institute (NIH) $248,357
Detection of protein glycosylation HHSN261201300047C National Cancer Institute (NIH) $947,400
Other functions - pincer-based in-process analyzer for biologics HHSN261201200081C National Cancer Institute (NIH) $995,488
Sbir phase II pincer assay HHSD200201252857C CDC Office of Acquisition Services $737,952
Sbir topic 304 phase I "development of blood-based methods for the detection of cancer recurrence in post-therapy… HHSN261201100124C National Cancer Institute (NIH) $298,601

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Fluorescence-based sequence-specific imaging of RNA modifications - recent technological advances that allowed for… R44GM137636 National Institute of General Medical Sciences (NIH) $1,490,030
Fluorescence-based sequence-specific imaging of RNA modifications R43GM137636 National Institute of General Medical Sciences (NIH) $224,894
Developing novel immunoassays specific for thyroid stimulating and tshblocking autoantibodies R44DK115298 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $1,985,003
Developing novel immunoassays specific for thyroid stimulating and TSH blocking autoantibodies R43DK115298 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $223,638
Developing specific, rapid and cost-effective immunoassays for zika detection R43AI131833 National Institute of Allergy and Infectious Diseases (NIH) $299,979

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Inanovate Inc. UEI K4DLR58DKLH9 Sioux Falls, SD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Molecular Diagnostic Services UEI PJ83K2PMLUV6 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

SBA capabilities narrative

From the vendor's SBA profile

Bioassay developement

Quick answers

Is Mediomics LLC registered in SAM.gov?

Yes. Mediomics LLC's SAM.gov registration is active through September 30, 2027.

What is Mediomics LLC's CAGE code?

Mediomics LLC's CAGE code is 46JZ5, and its Unique Entity ID (UEI) is TT17CQEWLNF1.

What is Mediomics LLC's most recent federal award?

Mediomics LLC's most recent federal grant award is Fluorescence-based sequence-specific imaging of RNA modifications - recent technological advances that allowed for… (R44GM137636), from National Institute of General Medical Sciences (NIH), on July 1, 2020.

On GovTribe

See Mediomics LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe